(CNSX:ACT.CN),(OTC US:ACTHF),(Other OTC:ACTHF),(Boerse Frankfurt – Freiverkehr:9D5),(NASDAQ:ADUR), LONDON, Ontario, Aug. 14, 2025 (GLOBE NEWSWIRE) — Aduro Clean Technologies Inc. (“Aduro” or the “Company“) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower-value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st century, […]

(TSX-V:OCO),(Boerse Frankfurt – Freiverkehr:OR6),(OTC US:ORRCF),(Other OTC:ORRCF), VANCOUVER, Canada, Aug. 14, 2025 (GLOBE NEWSWIRE) — Vancouver, CANADA. – August 14th, 2025 – Oroco Resource Corp. (TSX-V: OCO; OTCQB: ORRCF) (“Oroco” or “the Company“) extends its congratulations to Hudbay Minerals Inc. (“Hudbay“) for its agreement with Mitsubishi Corporation (“Mitsubishi“) announced on August 13th 2025, whereby Mitsubishi will

(NYSE MKT:SRXH), TAMPA, Fla., Aug. 14, 2025 (GLOBE NEWSWIRE) — SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”), a leading global health and wellness company, today announced that further to the previously disclosed grant of an Initial Order under the federal Companies' Creditors Arrangement Act by the Ontario Superior Court of Justice to the

Nomination recognizes SEED's pioneering work inmolecular glue development in targeted protein degradationto address high unmet medical needs Follows recent FDA IND clearance for SEED'slead asset RBM39 degrader ST-01156 KING OF PRUSSIA, Pa., Aug. 14, 2025 (GLOBE NEWSWIRE) — SEED Therapeutics, Inc. (“SEED”), a clinical-stage biotechnology company pioneering rational molecular glue degraders for historically undruggable disease

SAN DIEGO, Aug. 14, 2025 (GLOBE NEWSWIRE) — Denovo Biopharma LLC, a pioneer in applying precision medicine to development of innovative drugs, today announced that company management will participate in upcoming August and September investor events. The presentations will highlight Denovo's lead asset, liafensine, a first-in-class antidepressant in Phase 3 development. Liafensine has shown robust

(NASDAQ:UNCY), – Type A Meeting requested with U.S. Food and Drug Administration (FDA) for resolution of the Complete Response Letter (CRL) for oxylanthanum carbonate (OLC) – OLC pivotal study data, published in the Clinical Journal of the American Society of Nephrology (CJASN), demonstrated OLC was well tolerated and enabled serum phosphate control in over 90%

(NasdaqGM:ATAI), Planned strategic combination with Beckley Psytech expected to solidify position as global leader in transformative, psychedelic-based mental health therapies with a short time in-clinic Reported positive topline data from the core, blinded stage of the Phase 2b clinical trial of BPL-003 (intranasal mebufotenin benzoate) in patients with treatment-resistant depression (TRD) BPL-003 met its primary

(TSX:AYA),(OTC US:AYASF),(Other OTC:AYASF), MONTREAL, Aug. 14, 2025 (GLOBE NEWSWIRE) — Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) (“Aya” or the “Corporation”) today announced second quarter financial and operational results for the three-month period ended June 30, 2025. All amounts are in US dollars, unless otherwise stated. Q2-2025 Highlights Operational Silver production of 1.04

(NASDAQ:FTLF), OMAHA, NE, Aug. 14, 2025 (GLOBE NEWSWIRE) — FitLife Brands, Inc. (“FitLife” or the “Company“) (NASDAQ: FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced financial results for the second quarter ended June 30, 2025. Highlights for the second quarter ended June 30, 2025 include: Total revenue was $16.1

(TSX-V:RFX), NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, Aug. 14, 2025 (GLOBE NEWSWIRE) — Reeflex Solutions Inc. (TSXV: RFX) (“Reeflex” or the “Company“) is pleased to announce its wholly-owned subsidiary, Coil Solutions Inc. (“CSI“), a leading manufacturer of coiled tubing injectors and related energy services equipment,